{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:10:41Z","timestamp":1788189041883,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ophtha.2013.03.044","type":"journal-article","created":{"date-parts":[[2013,6,3]],"date-time":"2013-06-03T18:01:33Z","timestamp":1370282493000},"page":"2197-2203","source":"Crossref","is-referenced-by-count":57,"title":["Topical Cyclosporine in the Treatment of\u00a0Allergic Conjunctivitis"],"prefix":"10.1016","volume":"120","author":[{"given":"Kelvin Ho-Nam","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Song","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"228","key":"10.1016\/j.ophtha.2013.03.044_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0420.1999.tb01164.x","article-title":"Classification of ocular atopic\/allergic disorders and conditions: an unsolved problem","author":"Calonge","year":"1999","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"10.1016\/j.ophtha.2013.03.044_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1164\/ajrccm.149.2.8306030","article-title":"Prevalence of asthma and atopy in two areas of West and East Germany","volume":"149","author":"von Mutius","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ophtha.2013.03.044_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1542-0124(12)70140-4","article-title":"Ocular allergic disease: mechanisms, disease sub-types, treatment","volume":"1","author":"Abelson","year":"2003","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2013.03.044_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"230","key":"10.1016\/j.ophtha.2013.03.044_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1600-0420.2000.078s230038.x","article-title":"Epidemiological study of 134 subjects with allergic conjunctivitis","author":"Belfort","year":"2000","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"10.1016\/j.ophtha.2013.03.044_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ACI.0b013e3282ef8674","article-title":"Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities","volume":"7","author":"Leonardi","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2013.03.044_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/14728214.10.3.505","article-title":"Emerging drugs for ocular allergy","volume":"10","author":"Leonardi","year":"2005","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.ophtha.2013.03.044_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.iac.2007.12.001","article-title":"Ocular allergy treatment","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ophtha.2013.03.044_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.03.044_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00003226-199311000-00008","article-title":"Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sj\u00f6gren's syndrome","volume":"12","author":"Power","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2013.03.044_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9394(14)70579-3","article-title":"An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis","volume":"121","author":"el-Asrar","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.03.044_bib12","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A\u00a0randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.03.044_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.03.044_bib14","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","article-title":"6.4.11: search filters","author":"Lefebvre","year":"2011"},{"key":"10.1016\/j.ophtha.2013.03.044_bib15","unstructured":"Deeks JJ, Higgins JP, Altman DG, Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: Higgins JP, Altman DG, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available at: http:\/\/handbook.cochrane.org\/. Accessed March 4, 2013."},{"key":"10.1016\/j.ophtha.2013.03.044_bib16","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","article-title":"7.7.3: data extraction for continuous outcomes","author":"Higgins","year":"2011"},{"key":"10.1016\/j.ophtha.2013.03.044_bib17","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","article-title":"Assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"key":"10.1016\/j.ophtha.2013.03.044_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis","volume":"41","author":"Kilic","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.03.044_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","article-title":"Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis","volume":"89","author":"Pucci","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ophtha.2013.03.044_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.03.044_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A\u00a0randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.03.044_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/eye.2001.10","article-title":"Topical cyclosporin A in the management of vernal keratoconjunctivitis","volume":"15","author":"Gupta","year":"2001","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2013.03.044_bib23","series-title":"Clinical Ocular Pharmacology","first-page":"163","article-title":"Anti-inflammatory drugs","author":"Jaanus","year":"1989"},{"key":"10.1016\/j.ophtha.2013.03.044_bib24","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","article-title":"Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years","volume":"112","author":"Barber","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.03.044_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.03.044_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0953-4431(99)00004-1","article-title":"Vernal vs. atopic keratoconjunctivitis","volume":"11","author":"Wong","year":"1999","journal-title":"Clin Eye Vis Care"},{"key":"10.1016\/j.ophtha.2013.03.044_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":"Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642013003291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642013003291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T10:55:23Z","timestamp":1539600923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642013003291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0161642013003291"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2013.03.044","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}